app_store_button

google_play_button

Details page - Device banner - 894x1036

Step into an infinite world of stories

Listen and read

The New York Times

This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.

The Daily

“Wicked” was one of the biggest movies of 2024. It was culturally ubiquitous, a box office smash and an Oscar nominee for Best Picture. Now, a year later, “Wicked: For Good” arrives in theaters to finish the tale of the complicated friendship between Glinda the Good Witch and Elphaba, the Wicked Witch of the West. Can “Wicked: For Good” be the sensation that its predecessor was? Will it inject new life into a movie business that has suffered a historically bad business year? Will it satisfy the legions of “Wicked” fans who have been waiting to see their favorite musical brought to the big screen?

Gilbert Cruz is joined by Kyle Buchanan, a pop culture reporter for The New York Times who profiled the stars of “Wicked,” and Madison Malone Kircher, a reporter for the Styles desk and affirmed “Wicked” fanatic, to discuss what “Wicked: For Good” means for the movies.

 

On Today’s Episode

Madison Malone Kircher is a reporter covering internet culture for The Times.

Kyle Buchanan is a pop culture reporter and serves as The Projectionist, the awards season columnist for The New York Times.

Photo: Universal Pictures

 

Additional Reading

Ariana Grande Still Has Surprises in Store

There Have Been Dozens of “Wicked” Interviews. Why Did This One Go Viral?

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Sunday Special: Wicked, Good?

The writer and YouTube star on trying to get back to the experiences that make us feel alive.

 • Thoughts? Email us at 
theinterview@nytimes.com • Watch our show on YouTube: 
youtube.com/@TheInterviewPodcast • For transcripts and more, visit: 
nytimes.com/theinterview

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

'The Interview': John Green Knows That No One Really Loves You on the Internet

Since starting his second term, President Trump has thrown the full weight of the federal government behind the denying the idea of transgender identity, and pushing to prevent trans minors from getting gender-affirming medical care.

Two parents of a trans child discuss facing the scramble of supporting their child, and their fears of becoming targets of the government.

Guest: The parents of Allie, who is trans.

Background reading: 

Hospitals are limiting gender treatment for trans minors • , even in blue states.
 • States have sued over 
Mr. Trump’s efforts to end pediatric transgender medical care • .
Trans youth are rattled by efforts to ban gender care • . So are hospitals.

Photo: Christopher Capozziello for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Parenting a Trans Kid in Trump’s America

After years of soaring optimism and colossal investment, Wall Street has begun to seriously question whether the frenzy for A.I. is justified.

Cade Metz, who covers technology for The New York Times, explains why Silicon Valley companies believe so fervently in A.I. and why they’re willing to take enormous risks to deliver on its promise.

Guest: Cade Metz, a technology reporter for The New York Times.

Background reading: 

 • Why debt funding is 
ratcheting up the risks • of the A.I. boom.
 • Amazon, Google, Meta, Microsoft and OpenAI 
plan to spend at least $325 billion by the end of the year • in pursuit of A.I.

Photo: Scott Ball for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Is There an A.I. Bubble? And What if It Pops?

Congressional Republicans on Tuesday overwhelmingly approved a bill to release all of the files related to the sex offender Jeffrey Epstein — a bill that President Trump spent months trying to kill.

The Times correspondents Anni Karni and Carl Hulse explain how a rebellion started by a handful of Republican lawmakers became a partywide mutiny, and Representative Thomas Massie talks about his role in bringing about the vote.

Guest:

Annie Karni • , a congressional correspondent at The New York Times.
Carl Hulse • , the chief Washington correspondent for The Times.
Representative Thomas Massie • , Republican of Kentucky.

Background reading: 

 • The vote to approve was 
a stunning turn • for an effort that Republican leaders had worked for months to block.
 • For Mr. Trump, the Epstein scandal is 
the story that won’t go away • .

Photo: Tierney L. Cross/The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Congress Orders Trump to Release the Epstein Files

For the first time in 30 years, the annual U.N. conference on climate change is taking place without top government representation from the United States. China has emerged as the top dog at the summit and is poised to become the world’s supplier of green energy technology.

David Gelles and Brad Plumer explain the growing showdown between global superpowers over the future of energy.

Guest:

David Gelles • , a reporter on the New York Times climate team who leads The Times’s Climate Forward 
newsletter • .
Brad Plumer • , a New York Times reporter based in Washington, covering technology and policy efforts to address global warming.

Background reading: 

There’s a race to power the future • . China is pulling away.
 • At a climate summit without the U.S., 
allies and rivals call for action • .

Photo: Gilles Sabrie for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

The Future of Energy Has Arrived — Just Not in the U.S.

When President Trump proposed the introduction of a 50-year mortgage, he challenged a bedrock of the American housing market and financial system. He also revealed how desperate the administration is to lower prices for consumers.

Conor Dougherty, who covers housing and development, explains what’s attractive about the idea and its potential drawbacks — and why housing affordability is such an intractable problem.

Guest: Conor Dougherty, a reporter for The New York Times covering housing and development for more than a decade.

Background reading: 

 • The Trump administration is 
facing backlash from U.S. consumers • as higher costs from tariffs blunt wage gains.
 • Many Americans bought their first houses during the pandemic, when 
mortgage rates dipped to record lows • . Now, some feel trapped.

Photo: Joe Raedle/Getty Images

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Unpacking Trump’s 50-Year Mortgage Proposal

There was once a time when documentaries could be found only on public television or in art-house cinemas. But today, documentaries are more popular and accessible than ever, with streaming services serving up true crime, celebrity documentaries, music documentaries and so much more.

On today’s Sunday Special, Gilbert is joined by The New York Times’s chief television critic, James Poniewozik, and Alissa Wilkinson, a Times film critic, to talk about the documentaries that are worth your viewing time.

 

On Today’s Episode:

James Poniewozik is the chief TV critic for The Times.

Alissa Wilkinson is a movie critic at The Times, and writes the Documentary Lens column.

 

Background Reading:

What ‘The American Revolution’ Says About Our Cultural Battles

‘Come See Me in the Good Light’: The Sweetness After a Terminal Diagnosis

 

 

Discussed on this episode:

“The American Revolution,” 2025, directed by Ken Burns, Sarah Botstein and David Schmidt

“The Alabama Solution,” 2025, directed by Andrew Jarecki and Charlotte Kaufman

“The Jinx: The Life and Deaths of Robert Durst,” 2015, directed by Andrew Jarecki

“Making a Murderer,” 2015, directed by Laura Ricciardi and Moira Demos

“The Yogurt Shop Murders,” 2025, directed by Margaret Brown

“The Perfect Neighbor,” 2025, directed by Beet Gandbhir

“The Last Dance,” 2020, directed by Jason Hehir

“Copa 71,” 2023, directed by Rachel Ramsay and James Erkine

“Cheer,” 2020, created by Greg Whiteley

“Last Chance U,” 2016, directed by Greg Whiteley, Adam Ridley and Luke Lorentzen

“Pee-wee as Himself,” 2025, directed by Matt Wolf

“The Remarkable Life of Ibelin,” 2024, directed by Benjamin Ree

“Ladies & Gentlemen … 50 Years of SNL Music,” 2025, directed by Questlove

“Cameraperson,” 2016, directed by Kirsten Johnson

“An American Family,” 1973, created by Craig Gilbert

“Look Into My Eyes,” 2024, directed by Lana Wilson

“When We Were Kings,” 1996, directed by Leon Gast

 

Photo: Mike Doyle/American Revolution Film Project and Florentine Films

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Sunday Special: A Sea of Streaming Docs

The longtime editor and chronicler of the elite says she’s liberated and is letting it rip.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

'The Interview': Tina Brown on Epstein, the Über-Rich and Her Most Burning Resentments

Drugs like Ozempic and Zepbound have revolutionized weight loss. And starting next year, the drugs are going to become more affordable for Americans because of a deal struck with pharmaceutical companies by the Trump administration.

Eshe Nelson, who covers economics and business news, explains how the change has its origins in a huge business blunder from the creator of Ozempic, Novo Nordisk.

Guest: Eshe Nelson, a reporter for The New York Times based in London, where she covers economics and business news.

Background reading: 

 • How 
Ozempic’s maker lost its shine • after creating a wonder drug.
What Trump’s new drug pricing deal means • for people with obesity.

Photo: Sergei Gapon/Agence France-Presse — Getty Images

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Is There an A.I. Bubble? And What if It Pops?

Listen and read

Other podcasts you might like ...